Alembic Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Profit before tax

345.93

658.01

1,416.60

1,166.79

764.63

Net cashflow-operating activity

730.25

545.26

1,485.30

539.75

808.80

Net cash used in investing activity

-460.98

-368.72

-925.55

-822.31

-753.59

Netcash used in fin. activity

-261.16

-216.64

-533.60

166.13

79.67

Net inc/dec in cash and equivlnt

8.11

-40.10

25.22

-116.02

134.81

Cash and equivalnt begin of year

13.56

53.66

28.22

144.24

9.45

Cash and equivalnt end of year

21.67

13.56

53.44

28.22

144.26